Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB AUROBINDO PHARMA DR. REDDYS LAB/
AUROBINDO PHARMA
 
P/E (TTM) x 19.7 23.0 85.8% View Chart
P/BV x 4.4 2.4 186.6% View Chart
Dividend Yield % 0.6 0.3 236.0%  

Financials

 DR. REDDYS LAB   AUROBINDO PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
AUROBINDO PHARMA
Mar-23
DR. REDDYS LAB/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,656715 651.5%   
Low Rs3,788397 953.3%   
Sales per share (Unadj.) Rs1,481.4424.2 349.2%  
Earnings per share (Unadj.) Rs270.732.9 822.7%  
Cash flow per share (Unadj.) Rs345.754.1 638.6%  
Dividends per share (Unadj.) Rs40.003.00 1,333.3%  
Avg Dividend yield %0.90.5 175.6%  
Book value per share (Unadj.) Rs1,389.6458.1 303.4%  
Shares outstanding (eoy) m166.53585.94 28.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.3 217.4%   
Avg P/E ratio x15.616.9 92.3%  
P/CF ratio (eoy) x12.210.3 118.9%  
Price / Book Value ratio x3.01.2 250.3%  
Dividend payout %14.89.1 162.1%   
Avg Mkt Cap Rs m703,039325,753 215.8%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46635,223 131.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,697248,554 99.3%  
Other income Rs m10,5552,906 363.2%   
Total revenues Rs m257,252251,460 102.3%   
Gross profit Rs m63,86037,070 172.3%  
Depreciation Rs m12,50212,446 100.5%   
Interest Rs m1,4281,405 101.7%   
Profit before tax Rs m60,48526,125 231.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,4126,849 225.0%   
Profit after tax Rs m45,07319,277 233.8%  
Gross profit margin %25.914.9 173.6%  
Effective tax rate %25.526.2 97.2%   
Net profit margin %18.37.8 235.6%  
BALANCE SHEET DATA
Current assets Rs m203,161214,599 94.7%   
Current liabilities Rs m85,721114,938 74.6%   
Net working cap to sales %47.640.1 118.7%  
Current ratio x2.41.9 126.9%  
Inventory Days Days7921 384.2%  
Debtors Days Days10766 163.5%  
Net fixed assets Rs m112,638176,668 63.8%   
Share capital Rs m833586 142.2%   
"Free" reserves Rs m230,571267,813 86.1%   
Net worth Rs m231,404268,399 86.2%   
Long term debt Rs m1,2786,190 20.6%   
Total assets Rs m315,799392,125 80.5%  
Interest coverage x43.419.6 221.2%   
Debt to equity ratio x00 23.9%  
Sales to assets ratio x0.80.6 123.2%   
Return on assets %14.75.3 279.2%  
Return on equity %19.57.2 271.2%  
Return on capital %26.610.0 265.4%  
Exports to sales %52.233.7 155.0%   
Imports to sales %16.815.3 109.8%   
Exports (fob) Rs m128,80383,703 153.9%   
Imports (cif) Rs m41,48438,060 109.0%   
Fx inflow Rs m128,80385,483 150.7%   
Fx outflow Rs m41,48441,447 100.1%   
Net fx Rs m87,31944,036 198.3%   
CASH FLOW
From Operations Rs m58,87523,868 246.7%  
From Investments Rs m-41,373-39,778 104.0%  
From Financial Activity Rs m-26,86118,144 -148.0%  
Net Cashflow Rs m-9,0732,298 -394.9%  

Share Holding

Indian Promoters % 26.7 48.8 54.7%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 47.3 41.3 114.4%  
FIIs % 28.6 20.7 138.1%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 48.2 120.4%  
Shareholders   257,794 241,944 106.6%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs Aurobindo Pharma Share Price Performance

Period Dr. Reddys Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 1.78% 1.82% 1.18%
1-Month -4.23% 5.96% -0.75%
1-Year 35.93% 113.07% 61.82%
3-Year CAGR 10.85% 7.78% 18.16%
5-Year CAGR 17.77% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.